Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

April 7, 2021

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Afatinib

DRUG

Cetuximab

Trial Locations (33)

37000

Tours - CHU, Tours

58033

Nevers - CH, Nevers

63000

Nouvel Hopital Civil - Pneumologie, Strasbourg

64046

Pau - CH, Pau

72000

Centre Hospitalier - Pneumologie, Le Mans

74374

Annecy - CH, Annecy

75020

AP-HP Hopital Tenon - Pneumologie, Paris

Unknown

Centre Hospitalier du Pays d'Aix, Aix-en-Provence

Clinique de L'Europe, Amiens

Angers - CHU, Angers

Bordeaux - Institut Bergonié, Bordeaux

Bordeaux - Polyclinique Nord, Bordeaux

Boulogne - Ambroise Paré, Boulogne-Billancourt

Clermont-Ferrand - CHU, Clermont-Ferrand

CH, Colmar

CHRU Grenoble, Grenoble

CHRU de Lille, Lille

Lille - Polyclinique de la Louvière, Lille

Lyon - Hôpital Privé Jean Mermoz, Lyon

Institut Paoli Calmette, Marseille

Montpellier - GCS Centre de Cancérologie du Grand Montpellier, Montpellier

CH de Mulhouse, Mulhouse

Nantes - ICO René Gauducheau, Nantes

Centre Antoine Lacassagne, Nice

Orléans - Hôpital de la Source, Orléans

Paris - APHP Bichat, Paris

Paris - APHP Saint-Louis, Paris

Pontoise - CH, Pontoise

Centre Hospitalier, Saint-Quentin

Centre Hospitalier Intercommunal, Toulon

HIA Saint Anne, Toulon

CH de Villefranche - Pneumologie, Villefranche

Villeneuve d'Ascq - Hôpital Privé, Villeneuve-d'Ascq

All Listed Sponsors
lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER

NCT02716311 - Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer | Biotech Hunter | Biotech Hunter